Cited by 363Antifungal resistance and susceptibilityFungal Infections and StudiesOcular Infections and Treatments

Therapeutic Approaches in Patients With Candidemia: Evaluation in a Multicenter, Prospective, Observational Study

Nguyen, M. Hong·1995·Archives of Internal Medicine

Abstract

OBJECTIVES: To evaluate the morbidity and mortality of Candida fungemia and to assess the efficacy of low- vs high-dose amphotericin B and fluconazole vs amphotericin B in patients with candidemia. METHODS: Multicenter, prospective, observational study of 427 consecutive patients with candidemia. RESULTS: The mortality rate for patients with candidemia was 34%. The mortality rate for patients with catheter-related candidemia in whom the catheters were retained was significantly higher than that of patients in whom the catheters were removed (41% vs 21%, P < .001). We found no overall difference in mortality in patients treated with low-dose (total amphotericin B dose of < or = 500 mg) (13%) vs high-dose amphotericin B (total amphotericin B dose of > 500 mg) (15%), but the group treated with a low dose had fewer side effects (40%) than those treated with a high dose (55%) (P = .03). Fluconazole was as efficacious as amphotericin B in the therapy of candidemia, even when stratified by risk factors for mortality. Fewer side effects were seen with fluconazole (12%) compared with amphotericin B (44%) (P < .001). CONCLUSIONS: In selected patients with candidemia, low-dose amphotericin B was as efficacious as high-dose amphotericin B. Based on other studies and ours, fluconazole seems to be an alternative therapeutic option to amphotericin B in selected patients.

Integrity signals

Registry

Crossref · 10.1001/archinte.1995.00430220087009

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two large randomized studies and 2 large observational studies have demonstrated that fluconazole (400 mg/day) and amphotericin B deoxycholate (0.5-0.6 mg/kg per day) are similarly effective as therapy.

    “Two large randomized studies [105, 106] and 2 large observational studies [107, 108] have demonstrated that fluconazole (400 mg/day) and amphotericin B deoxycholate (0.5-0.6 mg/kg per day) are similarly effective as therapy.”

    From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [108]

  • In an individual patient, it is difficult to determine the relative contributions of the gut and a catheter as primary sources of fungemia.

    “in an individual patient, it is difficult to determine the relative contributions of the gut and a catheter as primary sources of fungemia [107,108,118].”

    From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [108]

  • In neutropenic patients, the gut is a source for disseminated candidiasis, evident from autopsy studies.

    “In neutropenic patients, the role of the gut as a source for disseminated candidiasis is evident from autopsy studies”

    From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [108]

  • Catheter removal is associated with reduced mortality in adults and neonates with candidemia.

    “includes data in which catheter removal was associated with reduced mortality in adults [108, 116] and neonates [117].”

    From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [108]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nguyen, M. H.
Affiliations
University of Pittsburgh (US)
Corresponding author
Nguyen, M. Hong
Venue
Archives of Internal Medicine
Published
1995-12-11
Volume
155
Issue
22
Pages
2429
ISSN
0003-9926 (ISSN-L)
OpenAlex
W2132633210
Cited by
363
References
24
Citations by year
2025: 5 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 7 · 2019: 4 · 2018: 5 · 2017: 4 · 2016: 5 · 2015: 9 · 2014: 10 · 2013: 14 · 2012: 11
FWCI
9.71
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords
candidemia, amphotericin B, fluconazole, mortality, catheter-related candidemia, catheter removal, antifungal therapy, adverse drug reactions
MeSH terms
Aged, Amphotericin B, Antifungal Agents, Candidiasis, Catheters, Indwelling, Humans, Middle Aged, Prospective Studies, Risk Factors, Fluconazole, Fungemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review